Depemokimab

JUN 10, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Exdensur (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval for labeling change to Exdensur (depemokimab); regulatory action does not report clinical trial outcomes or efficacy data.